Volume No. :   8

Issue No. :  4

Year :  2018

ISSN Print :  2231-5640

ISSN Online :  2231-5659


Registration

Allready Registrered
Click to Login

A Study on Banned Drugs in India: A Review



Address:   Manohar D. Kengar*, Ganesh B. Vambhurkar Asha M. Jagtap, Akshata S. Gavade, Manojkumar M. Nitalikar
Rajarambapu College of Pharmacy, Kasegaon, Dist–Sangli, Maharashtra, India–415404.
*Corresponding Author
DOI No: 10.5958/2231-5659.2018.00043.7

ABSTRACT:
The numbers of single drugs as well as fixed dose combinations drugs are banned in other countries but they have manufacturing, marketing and distribution in India. Over the counter availability of banned drugs sufficient adverse drug reactions data about these drugs have not been reported. The adverse effect of drugs is detected by regular monitoring after the drug released called pharmacovigilance. The Indian regulatory authority monitoring the new drug in market before pre-clinical study and permit to sold in market. The banned dugs prescribed over the counter the responsible as unawareness of physicians and patients, poverty, self-medication, carelessness of regulatory authorities, non availability of appropriate drugs, high cost, and communication. The Government of India is in the process of developing a regulatory regime designed to ensure the quality, safety and performance of medical devices.
KEYWORDS:
Banned Drug, Indian Drug, FDA, Adverse drug reaction, Pharmacovigilance
Cite:
Manohar D. Kengar, Ganesh B. Vambhurkar Asha M. Jagtap, Akshata S. Gavade, Manojkumar M. Nitalikar. A Study on Banned Drugs in India: A Review. Asian J. Res. Pharm. Sci. 2018; 8(4): 258-260.
[View HTML]     



Visitor's No. :   109015